LYEL stock news · Lyell Immunopharma, Inc.
Get alerts for LYEL
Follow Lyell Immunopharma, Inc. (LYEL) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for LYELFree on the App Store and Google Play, or on the web.
Lyell Immunopharma is letting stockholders sell 7.43 million shares of its common stock.
Bad for LYELLyell filed to register 7.43 million existing shares for sale by shareholders. The company gets no money, making this unfavorable for its shares.
Lyell Immunopharma, Inc. shares news about finishing the tech transfer for LYL273.
NeutralLyell completed the LYL273 manufacturing transfer and noted a trial timeline update; because the filing lacks timeline detail, the filing does not change Lyell's outlook.